JP2012523388A - プリン作動性p2x7受容体結合剤を用いた中枢神経系のイメージング - Google Patents

プリン作動性p2x7受容体結合剤を用いた中枢神経系のイメージング Download PDF

Info

Publication number
JP2012523388A
JP2012523388A JP2012503993A JP2012503993A JP2012523388A JP 2012523388 A JP2012523388 A JP 2012523388A JP 2012503993 A JP2012503993 A JP 2012503993A JP 2012503993 A JP2012503993 A JP 2012503993A JP 2012523388 A JP2012523388 A JP 2012523388A
Authority
JP
Japan
Prior art keywords
vivo imaging
imaging agent
subject
agent according
precursor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2012503993A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012523388A5 (https=
Inventor
アレクザンドラー ジャクソン,
モリソン・アイベソン・ベロニック
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Publication of JP2012523388A publication Critical patent/JP2012523388A/ja
Publication of JP2012523388A5 publication Critical patent/JP2012523388A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0453Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2012503993A 2009-04-09 2010-04-06 プリン作動性p2x7受容体結合剤を用いた中枢神経系のイメージング Withdrawn JP2012523388A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16789309P 2009-04-09 2009-04-09
GBGB0906274.6A GB0906274D0 (en) 2009-04-09 2009-04-09 Imaging the central nervous system
GB0906274.6 2009-04-09
US61/167,893 2009-04-09
PCT/EP2010/054517 WO2010115881A1 (en) 2009-04-09 2010-04-06 Imaging the central nervous system with purinergic p2x7 receptor binding agents

Publications (2)

Publication Number Publication Date
JP2012523388A true JP2012523388A (ja) 2012-10-04
JP2012523388A5 JP2012523388A5 (https=) 2013-05-16

Family

ID=40750455

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012503993A Withdrawn JP2012523388A (ja) 2009-04-09 2010-04-06 プリン作動性p2x7受容体結合剤を用いた中枢神経系のイメージング

Country Status (6)

Country Link
US (1) US20120034165A1 (https=)
EP (1) EP2416808A1 (https=)
JP (1) JP2012523388A (https=)
CN (1) CN102834120A (https=)
GB (1) GB0906274D0 (https=)
WO (1) WO2010115881A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI618544B (zh) 2006-12-26 2018-03-21 藍瑟斯醫學影像公司 使心臟神經分布顯像之配位體
AU2011253052B2 (en) 2010-05-11 2015-05-14 Lantheus Medical Imaging, Inc. Compositions, methods and systems for the synthesis and use of imaging agents
US20150352185A1 (en) * 2010-11-16 2015-12-10 Denis G. Kay Method for increasing neprilysin expression and activity
EP2753605B1 (en) 2011-09-09 2019-03-27 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
WO2020227159A2 (en) 2019-05-03 2020-11-12 Flagship Pioneering Innovations V, Inc. Methods of modulating immune activity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2627114A1 (en) * 2005-11-07 2007-05-18 Abbott Laboratories P2x7 receptor antagonists and methods of use
CA2645652A1 (en) 2006-03-16 2007-09-27 Renovis, Inc. Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
TWI464148B (zh) 2006-03-16 2014-12-11 Evotec Us Inc 作為p2x7調節劑之雙環雜芳基化合物與其用途
ATE489088T1 (de) * 2006-06-06 2010-12-15 Glaxo Group Ltd N- (phenylmethyl) -2- (1h-pyrazol-4-yl) acetamid- derivate als p2x7-antagonisten zur behandlung von schmerzen, entzündungen und neurodegeneration
WO2008064432A1 (en) 2006-12-01 2008-06-05 The University Of Sydney Polycyclic molecular compounds
GB0803729D0 (en) * 2008-02-29 2008-04-09 Ge Healthcare Ltd Imaging the central nervous system

Also Published As

Publication number Publication date
WO2010115881A1 (en) 2010-10-14
EP2416808A1 (en) 2012-02-15
GB0906274D0 (en) 2009-05-20
US20120034165A1 (en) 2012-02-09
CN102834120A (zh) 2012-12-19

Similar Documents

Publication Publication Date Title
JP5431954B2 (ja) InVivo造影剤
JP2009515940A (ja) 末梢ベンゾジアゼピンレセプター(pbr)親和性を有するインビボイメージング剤としての四環式インドール誘導体
JP2012523388A (ja) プリン作動性p2x7受容体結合剤を用いた中枢神経系のイメージング
RU2512288C2 (ru) Производные индола, подходящие для визуализации нейровоспаления
CA3100235A1 (en) Styrylbenzothiazole derivatives and uses in imaging
JP5787873B2 (ja) インビボイメージング用の放射性標識ピリジニル誘導体
JP2009538894A (ja) インビボイメージング化合物としての四環式オキサゼピン類
JP2013507345A (ja) インビボイメージング剤としてのフルマゼニルの[18f]標識類似体
EP2247316B1 (en) Imaging the central nervous system
US9186424B2 (en) Aryloxyanilide imaging agents
WO2020032038A1 (ja) モノアミンオキシダーゼbイメージングプローブ
Luthra et al. 18 F-Labelled Tracers for PET Oncology and Neurology Applications
JP2021102593A (ja) タウを画像化する新規化合物
Luthra et al. Oncology and Neurology Applications
McCardle Synthesis and characterisation of a radioligand for positron emission tomography imaging of the 5-HT 1A receptor
Morais et al. Author's Accepted Manuscript

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130328

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130328

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20131107